An example of such patients is shown in Figure 4A. In this B-NHL-NOS high-grade secondary CNS lymphoma, the levels of all five oncomiRs in the CSF began to decrease within 3 days after the initiation of therapy, and after a temporal increase in the third last time point, they finally decreased. This evidence concerns the gene PPIB and primary central nervous system lymphoma.